Pan-branch Ubiquitin TUBE-RAD23A (Magnetic Bead Conjugate) #64334
- IP
Product Information
Product Description
Product Usage Information
Add beads at a 1:20 dilution to cell lysates prepared in 1X Cell Lysis Buffer (10X) #9803. Mix overnight at 4°C. Wash five times in 1X Cell Lysis Buffer. For more details, refer to the Immunoprecipitation for Native Proteins protocol.
For bead washing and subsequent washing of affinity-purified complexes, the beads can be separated from solution using our 6-Tube Magnetic Separation Rack #7017. Place the tubes containing the beads in the Magnetic Separation Rack and wait 1 to 2 min for solution to clear before carefully removing the supernatant. Remove the tubes from the Magnetic Separation Rack, add new solution, and resuspend the beads by gently vortexing or rocking the tubes.
Storage
Protocol
Specificity / Sensitivity
Species Reactivity:
Source / Purification
Background
Substrate proteins are linked to ubiquitin using seven distinct ubiquitin lysine residues (Lys6, Lys11, Lys27, Lys29, Lys33, Lys48, and Lys63). Formation of a polyubiquitin chain occurs when a lysine residue of ubiquitin is linked to the carboxy-terminal glycine of another ubiquitin. Proteins polyubiquitinated at specific lysine residues display a tendency to be targeted for different processes; K48-linked polyubiquitin chains mainly target proteins for proteasomal degradation, while K63-linked polyubiquitin chains regulate protein function, subcellular localization, or protein-protein interactions (8). K63-linked polyubiquitin chains exert nonproteolytic functions in vivo, such as protein trafficking, kinase/phosphatase activation, and DNA damage control, all of which might be important in regulation of cancer survival and development (9,10).
Ubiquitin-associated (UBA) domains are protein regions that interact with ubiquitin. Tandem-repeated ubiquitin-binding entities (TUBEs) were designed by using four tandem UBA domains, based on the theory that tetraubiquitin chains are a minimum requirement for efficient proteasomal degradation (11). TUBEs designed with UBA domains from UBQLN1 and RAD23A bind to K48- and K63-linked tetraubiquitin chains and can used to efficiently purify ubiquitylated proteins from cell extracts (12).
- Ciechanover, A. (1998) EMBO J 17, 7151-60.
- Hochstrasser, M. (2000) Nat Cell Biol 2, E153-7.
- Hochstrasser, M. (2000) Science 289, 563-4.
- Bernardi, R. et al. (2000) Oncogene 19, 2447-54.
- Aberle, H. et al. (1997) EMBO J 16, 3797-804.
- Salomoni, P. and Pandolfi, P.P. (2002) Nat Cell Biol 4, E152-3.
- Jesenberger, V. and Jentsch, S. (2002) Nat Rev Mol Cell Biol 3, 112-21.
- Komander, D. (2009) Biochem Soc Trans 37, 937-53.
- Chen, Z.J. and Sun, L.J. (2009) Mol Cell 33, 275-86.
- Yang, W.L. et al. (2010) Oncogene 29, 4493-503.
- Thrower, J.S. et al. (2000) EMBO J 19, 94-102.
- Hjerpe, R. et al. (2009) EMBO Rep 10, 1250-8.
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.